Description
Research overview
PT-141, also known in the literature as bremelanotide, is a melanocortin receptor agonist derived from the alpha-MSH peptide family. In research settings it is commonly discussed in relation to MC3R, MC4R, and broader central melanocortin signaling pathways.
Research applications
- Melanocortin receptor binding, selectivity, and pathway-comparison studies.
- Structure-activity research involving alpha-MSH analogs and modified cyclic peptides.
- Central signaling models where melanocortin pathway activation is the variable of interest.
Catalog benefits
- 10mg lyophilized vial format for research inventory planning.
- Clear use classification and conservative product language with no dosing guidance.
- Consistent INPEP labeling for fast identification in the peptide catalog.
Research-use notice: This product is not intended to diagnose, treat, cure, or prevent disease and is not for human or animal consumption.
Reviews
There are no reviews yet.